Cargando…

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

Detalles Bibliográficos
Autores principales:	Iavarone, Massimo, D'Ambrosio, Roberta, Lampertico, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410797/ https://www.ncbi.nlm.nih.gov/pubmed/32771429 http://dx.doi.org/10.1016/j.jhep.2020.08.001

Ejemplares similares

High rates of 30-day mortality in patients with cirrhosis and COVID-19
por: Iavarone, Massimo, et al.
Publicado: (2020)

Letter regarding “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Medhat, Mohammed A., et al.
Publicado: (2020)

Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
por: Kim, Tae Hyung, et al.
Publicado: (2023)

Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
por: Iavarone, Massimo, et al.
Publicado: (2022)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Re: Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
por: Kirub, Ephrem
Publicado: (2023)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Jäntti, Toni, et al.
Publicado: (2021)

Reply
por: Pettoello-Mantovani, Massimo, et al.
Publicado: (2022)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Reply to Letter to the Editor: “Postpartum Infective Endocarditis with Enterococcus faecalis: Correspondence”
por: Etem Dural, İbrahim, et al.
Publicado: (2022)

Reply
por: DeBiasi, Roberta L.
Publicado: (2020)

Reply
por: Pettoello-Mantovani, Massimo
Publicado: (2022)

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
por: An, Jihyun, et al.
Publicado: (2022)

Reply to Letter to the Editor: “Cardiac Function in Uncomplicated COVID-19 Survivors: Correspondence”
por: Akbulut, Müge, et al.
Publicado: (2023)

Reply
por: Pettoello-Mantovani, Massimo, et al.
Publicado: (2020)

Vasoactive-inotropic score and pediatric septic shock mortality: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Reply to ‘Comment on ‘30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure’’
por: Hsieh, Wan-Hua, et al.
Publicado: (2018)

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
por: Iavarone, Massimo, et al.
Publicado: (2023)

Comment on “Routine Postsurgical Anesthesia Visit to Improve 30-day Morbidity and Mortality”: An Homage to Outcome Measures Beyond Unequivocal Treatment Targets
por: Bello, Corina, et al.
Publicado: (2023)

Predictors of mortality caused by hypothermia in Japan: Author's reply
por: Tokuda, Yasuharu, et al.
Publicado: (2021)

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”
por: Wang, Yijin, et al.
Publicado: (2020)

Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
por: Yu, Chenyan, et al.
Publicado: (2022)

Reply to Letter to Editor: Potent Anticoagulants are Associated with a Higher All-cause Mortality Rate after Hip and Knee Arthroplasty
por: Sharrock, Nigel E., et al.
Publicado: (2008)

Predicting the mortality of patients with Covid‐19 A machine learning approach: Correspondence
por: Ayyoubzadeh, Seyed Mohammad
Publicado: (2023)

Unplanned 30-Day Hospital Readmissions of Symptomatic Carotid and Vertebral Artery Dissection
por: Mehta, Tapan, et al.
Publicado: (2018)

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis
por: Grace, Josephine A., et al.
Publicado: (2020)

Author’s Reply: HFE Gene Mutations (C282Y and H63D) in a Group of Patients With Cryptogenic Cirrhosis
por: Geramizadeh, Bita
Publicado: (2012)

Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?
por: D'Ambrosio, Viola, et al.
Publicado: (2022)

Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality
por: Ahmed, H Shafeeq
Publicado: (2022)

REPLY TO THE AUTHORS: Re: One-day voiding diary in the evaluation of Lower Urinary Tract Symptoms in children
por: Franck, Hanny Helena Masson, et al.
Publicado: (2023)

Early Use of High-Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate? Authors’ Reply
por: Sim, Jae Kyeom, et al.
Publicado: (2023)

Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection”
por: Covino, Marcello, et al.
Publicado: (2022)

Reply to Letter to the Editor: “Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure: Correspondence”
por: Huang, Ying, et al.
Publicado: (2022)

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bnga7p12l882ea17ni6chn2bvv